A Budget Impact Model of the Addition of Telotristat Ethyl Treatment to the Standard of Care in Patients with Uncontrolled Carcinoid Syndrome
ConclusionsThe expected budget impact of adding telotristat ethyl to the standard of care in Sweden was relatively low, largely because of the rarity of carcinoid syndrome.
Source: PharmacoEconomics - Category: Health Management Source Type: research
More News: Brain | Cancer & Oncology | Carcinoid Tumor | Cardiology | Databases & Libraries | Diarrhoea | European Medicines Agency (EMA) | Health Management | Heart | Heart Disease | Neurology | Study | Sweden Health